Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT05097209 · UNKNOWN

Trial details

NCT number: NCT05097209
Sponsor: Wei Jiang
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2022-04-06
Primary completion: 2025-04-06
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.